484 related articles for article (PubMed ID: 19061836)
21. Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.
Chen D; Kon N; Zhong J; Zhang P; Yu L; Gu W
Mol Cell; 2013 Jul; 51(1):46-56. PubMed ID: 23747016
[TBL] [Abstract][Full Text] [Related]
22. FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53.
Molinuevo R; Freije A; de Pedro I; Stoll SW; Elder JT; Gandarillas A
Oncogene; 2017 Feb; 36(7):956-965. PubMed ID: 27452522
[TBL] [Abstract][Full Text] [Related]
23. Uncovering MYC's full oncogenic potential in the hematopoietic system.
Janz S
Oncogene; 2005 May; 24(22):3541-3. PubMed ID: 15782131
[TBL] [Abstract][Full Text] [Related]
24. Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.
Taylor AC; Schuster K; McKenzie PP; Harris LC
Mol Cancer; 2006 Nov; 5():53. PubMed ID: 17081294
[TBL] [Abstract][Full Text] [Related]
25. SNIP1: Myc's new helper in transcriptional activation.
Larsson LG
Mol Cell; 2006 Dec; 24(6):811-2. PubMed ID: 17189184
[TBL] [Abstract][Full Text] [Related]
26. ARF differentially modulates apoptosis induced by E2F1 and Myc.
Russell JL; Powers JT; Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Mol Cell Biol; 2002 Mar; 22(5):1360-8. PubMed ID: 11839803
[TBL] [Abstract][Full Text] [Related]
27. c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis.
Feng YC; Liu XY; Teng L; Ji Q; Wu Y; Li JM; Gao W; Zhang YY; La T; Tabatabaee H; Yan XG; Jamaluddin MFB; Zhang D; Guo ST; Scott RJ; Liu T; Thorne RF; Zhang XD; Jin L
Nat Commun; 2020 Oct; 11(1):4980. PubMed ID: 33020477
[TBL] [Abstract][Full Text] [Related]
28. MYC and the control of apoptosis.
McMahon SB
Cold Spring Harb Perspect Med; 2014 Jul; 4(7):a014407. PubMed ID: 24985130
[TBL] [Abstract][Full Text] [Related]
29. miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance.
Deng X; Liu Z; Liu X; Fu Q; Deng T; Lu J; Liu Y; Liang Z; Jiang Q; Cheng C; Fang W
Mol Ther; 2018 Apr; 26(4):1066-1081. PubMed ID: 29525743
[TBL] [Abstract][Full Text] [Related]
30. DNA-damaging drug-induced apoptosis sensitized by N-myc in neuroblastoma cells.
Li T; Wang L; Ke XX; Gong XY; Wan JH; Hao XW; Xu M; Xiang Z; Cui ZB; Cui H
Cell Biol Int; 2012 Apr; 36(4):331-7. PubMed ID: 21929510
[TBL] [Abstract][Full Text] [Related]
31. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
32. p53 represses c-Myc through induction of the tumor suppressor miR-145.
Sachdeva M; Zhu S; Wu F; Wu H; Walia V; Kumar S; Elble R; Watabe K; Mo YY
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3207-12. PubMed ID: 19202062
[TBL] [Abstract][Full Text] [Related]
33. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
34. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
[TBL] [Abstract][Full Text] [Related]
35. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
36. MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.
Zhang F; Zakaria SM; Högqvist Tabor V; Singh M; Tronnersjö S; Goodwin J; Selivanova G; Bartek J; Castell A; Larsson LG
Cell Cycle; 2018; 17(24):2697-2715. PubMed ID: 30526305
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.
Eischen CM; Woo D; Roussel MF; Cleveland JL
Mol Cell Biol; 2001 Aug; 21(15):5063-70. PubMed ID: 11438662
[TBL] [Abstract][Full Text] [Related]
38. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF
Oncogene; 2007 May; 26(20):2833-9. PubMed ID: 17099725
[TBL] [Abstract][Full Text] [Related]
39. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
Wagner AJ; Kokontis JM; Hay N
Genes Dev; 1994 Dec; 8(23):2817-30. PubMed ID: 7995520
[TBL] [Abstract][Full Text] [Related]
40. Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma.
Zacarías-Fluck MF; Massó-Vallés D; Giuntini F; González-Larreategui Í; Kaur J; Casacuberta-Serra S; Jauset T; Martínez-Martín S; Martín-Fernández G; Serrano Del Pozo E; Foradada L; Grueso J; Nonell L; Beaulieu ME; Whitfield JR; Soucek L
Genes Dev; 2023 Apr; 37(7-8):303-320. PubMed ID: 37024284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]